Medivolve Inc. (NEO: MEDV.NE) Stock Competitors & Peer Comparison
See MEDV.NE's competitors and their performance on the NEO and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MEDV.NE and its NEO peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MEDV.NE | CA$0.03 | +50.00% | 810.6K | -0.09 | -CA$0.35 | N/A |
| TMO.TO | CA$25.65 | +3.76% | 373B | 36.13 | CA$0.71 | N/A |
| TMO.NE | CA$25.63 | +3.68% | 353.6B | 1.87 | CA$13.68 | +0.26% |
| EDT.TO | CA$1.08 | +11.34% | 317M | -8.38 | -CA$0.13 | N/A |
| BUX.CN | CA$0.45 | +0.00% | 47.9M | -24.03 | -CA$0.02 | N/A |
| AKU.TO | CA$0.53 | +0.00% | 45.2M | -0.14 | -CA$3.82 | N/A |
| IZO.CN | CA$0.13 | +8.70% | 8.7M | -3.80 | -CA$0.03 | N/A |
| SZLS.TO | CA$0.04 | +0.00% | 4.9M | -1.61 | -CA$0.02 | N/A |
| SCRN.CN | CA$0.02 | +0.00% | 1.5M | -0.25 | -CA$0.06 | N/A |
Stock Comparison
Thermo Fisher Scientific Inc. (TSX: TMO.TO)
MEDV.NE vs TMO.TO Comparison November 2026
Medivolve Inc. (NEO: MEDV.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDV.NE stands at 810.6K. In comparison, TMO.TO has a market cap of 373B. Regarding current trading prices, MEDV.NE is priced at CA$0.03 on the NEO, while TMO.TO trades at CA$25.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDV.NE currently has a P/E ratio of -0.09, whereas TMO.TO's P/E ratio is 36.13. In terms of profitability, MEDV.NE's ROE is +2.13%, compared to TMO.TO's ROE of N/A. Regarding short-term risk, MEDV.NE is more volatile compared to TMO.TO. This indicates higher risk in terms of short-term price fluctuations for MEDV.NE.Check TMO.TO's competition here